Irrera et al. also shows that BAY 11-7082, an antagonist of NF-κB, can alleviate psoriasis-like dermatitis in a mouse model by inhibiting the NLRP3 inflammasome and the NF-κB pathway [30]. Here, NFKB1 is linked to psoriasis.